Stem Lowers FY24 Revenue Guidance From $600M-$700M To $567M-$667M Vs $672.29M Est.
Stem Lowers FY24 Revenue Guidance From $600M-$700M To $567M-$667M Vs $672.29M Est.
Outlook
外表
The Company is updating its full year 2024 guidance ranges as follows ($ millions, unless otherwise noted):
该公司正在更新其2024年全年指导区间如下 （除非另有说明，否则为百万美元):
| Previous | Updated* | |
| Revenue | $600 - $700 | $567 - $667 |
| Non-GAAP Gross Margin (%) | 15% - 20% | Unchanged |
| Adjusted EBITDA | $5 - $20 | Unchanged |
| Bookings | $1,500 - $2,000 | Unchanged |
| CARR (year-end) | $115 - $130 | Unchanged |
| Operating Cash Flow | Greater than $50 | Unchanged |
| 以前 | 已更新* | |
| 收入 | 600-700 美元 | 567-667 美元 |
| 非公认会计准则毛利率 (%) | 15%-20% | 不变 |
| 调整后 EBITDA | 5-20 美元 | 不变 |
| 预订 | 1,500-2,000 美元 | 不变 |
| CARR（年底） | 115-130 美元 | 不变 |
| 运营现金流 | 大于 50 美元 | 不变 |
See the section below titled "Reconciliations of Non-GAAP Financial Measures" for information regarding why Stem is unable to reconcile Non-GAAP Gross Margin and Adjusted EBITDA guidance to their most comparable financial measures calculated in accordance with GAAP.
有关Stem为何无法将非公认会计准则毛利率和调整后息税折旧摊销前利润指引与根据公认会计原则计算的最具可比性的财务指标进行对账的信息，请参阅以下标题为 “非公认会计准则财务指标对账” 的部分。
*Full year revenue guidance has been adjusted downward dollar-for-dollar solely as a result of the $33 million reduction in revenue.
*仅由于收入减少了3,300万美元，全年收入预期已按美元计算向下调整。
The Company reaffirms full year 2024 revenue projected quarterly performance as follows:
公司重申2024年全年收入的预计季度业绩如下：
| 1QA | 2QE | 3QE | 4QE | |
| Revenue | $25M | 10% | 32% | 54% |
| 1QA | 2QE | 3QE | 4QE | |
| 收入 | 2500 万美元 | 10% | 32% | 54% |
译文内容由第三方软件翻译。